Healthcare news on October 22, 2026

1. 0111:56 UTC

   Michigan Senate debate splits candidates over Medicare for All

   3 outlets · first: KMTV 3 News Now Omaha Regulation

   Machine summary El-Sayed said he supports Medicare for All and raising the income cap subject to Social Security taxes, while Rogers opposes Medicare for All, previously voted against the ACA and said he wants to reform it.

   1. In Michigan, Democrat Abdul El-Sayed said he supports Medicare for All and changes to the U.S. Supreme Court.
   2. According to reports, Mike Rogers, a Republican, is against Medicare for All; he once cast a vote opposing the Affordable Care Act and has expressed a desire to change the law.
   3. El-Sayed urged that the ceiling on earnings liable to Social Security taxes be lifted; in the debate, Rogers told legislators they should collaborate toward an answer but offered no concrete proposal.
   4. In Kansas, Adam Hamilton, the Democratic challenger, said he would refuse to back Sen. Chuck Schumer as majority leader were he to be elected.
   5. According to reports, Republican Sen. Roger Marshall argued tariffs are helping return manufacturing jobs to the United States.

   Reported by KMTV 3 News Now Omaha, Scripps News and wtvr.com.

   • Chuck Schumer
   • Affordable Care Act
   • Social Security
   • Medicare for All

2. 0211:31 UTC

   Coverage recordPajhwok Afghan News: “Pakistan’s pharmaceutical exports fall by over 30pc”

   2 outlets · first: Pajhwok Afghan News Market trends

   Reports ran between 11:31 and 16:00 UTC on Oct 22.

   The outlets that reported this event are listed with links to their reports; no summary of ours passed our automated checks for it, which says nothing about the event (how they work).

   Reported by Pajhwok Afghan News and pajhwok.com.

   • Pakistan
   • Pajhwok Afghan News

3. 0315:00 UTC

   South-East states step up Ebola preparedness after reported Abuja case

   2 outlets · first: nigerianeye.com Regulation

   Machine summary Governments in Nigeria's South-East have intensified Ebola Virus Disease surveillance and containment preparations after a reported case in Abuja, according to the reports, which state that no confirmed cases have been recorded in the zone. Abia State officials said isolation facilities are being equipped, personal protective equipment is being procured, and additional funding is needed for PPE, thermometers and hand sanitisers.

   1. South-East state governments intensified Ebola preparedness after a reported case in Abuja, with no confirmed cases recorded in the zone, according to the reports
   2. Abia State began equipping isolation facilities, procuring personal protective equipment and intensifying surveillance, Permanent Secretary Dr Blossom Uma-Kalu said
   3. Uma-Kalu said isolation centres require trained personnel, funding and treatment facilities, making one in every local government area impractical
   4. Health workers and public health teams were alerted after communication from the Federal Ministry of Health about the Abuja case, Uma-Kalu said

   Reported by nigerianeye.com and theeagleonline.com.ng.

   • Ebola Virus Disease
   • Federal Ministry of Health (Nigeria)

4. 0419:03 UTC

   Moderna and Merck vaccine cut melanoma recurrence risk by 42%

   2 outlets · first: STAT News Regulation

   Machine summary The trial covered roughly 1,100 patients whose tumors were surgically removed, and the combination also showed a 38% reduction in distant spread or death. Six melanoma specialists told CNBC that the data are clinically meaningful; Stéphane Bancel, Moderna's CEO, said his firm is completing a regulatory filing.

   1. CNBC reported that, in a Phase 3 trial involving roughly 1,100 patients, pairing the vaccine intismeran autogene with Keytruda cut the risk of recurrence of melanoma or death by 42% compared with Keytruda by itself.
   2. Trial results, which CNBC reported, showed that the combination lowered by 38% the risk of either cancer metastasizing to distant areas or death, relative to immunotherapy by itself.
   3. Six melanoma specialists told CNBC the Moderna and Merck cancer vaccine results were a clinically meaningful advance for patients treated surgically first.
   4. Moderna CEO Stéphane Bancel said in an interview before the results that the company is finishing a filing with regulators and aiming for full approval next year, CNBC reported.
   5. Trial participants were patients whose tumors had been removed by surgery and who had not received immunotherapy before their operation, CNBC reported.

   Reported by CNBC and STAT News.

   • Moderna
   • Keytruda
   • intismeran autogene

Each summary and its key facts are a machine summary of the reports linked under it; the outlets, times and counts come from those reports' own records. How a rundown is built.